Influenza coinfection inhibits control of mycobacterial infection in a human challenge model
Authors:
- Claire M. BroderickCBClaire M. Broderick
- Sam NicholsSNSam Nichols
- Dominic Habgood-CooteDHDominic Habgood-Coote
- Carlota Miranda-SoleCMCarlota Miranda-Sole
- Emily M. WhettlockEWEmily M. Whettlock
- Victoria J. WrightVWVictoria J. Wright
- Christopher W. WoodsCWChristopher W. Woods
- Christopher ChiuCCChristopher Chiu
Open Access
- 11 June 2026
- journal article
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Abstract
Mycobacterium tuberculosis infection is a dynamic continuum. Clinical outcomes reflect complex host-pathogen interactions. Epidemiological and animal studies have suggested influenza coinfection as a risk factor for progression from contained infection to active disease, but human studies have been lacking. Using a whole blood luminescent mycobacterial growth inhibition assay within a human influenza challenge study, we show that influenza infection reduces immunological control of mycobacterial growth. Transcriptome-wide RNA sequencing, cytokine and cellular analyses of subjects’ blood before and after influenza infection reveal that innate immune pathways, including type 1 interferon signalling, are activated by influenza but their subsequent responsiveness to mycobacteria is reduced, with multiple genes’ responses to BCG lux infection repressed by influenza coinfection. Our data suggest that influenza infection impairs immune mechanisms that contain mycobacterial growth and may be a risk factor for tuberculosis (TB) disease. Influenza vaccination might offer high risk, high prevalence populations protection against TB disease.Keywords
All Related Versions
Funding Information
- Wellcome (206508/Z/17/Z)
- Medical Research Foundation (MRF-160-0008-ELP-KAFO-C0801)
- Rosetrees Trust (Major Grant PGL22/100101)
- National Institute of Allergy and Infectious Diseases ((Centers of Excellence for Influenza Research and Surveillance. Contract no. HHSN272201400008C))
- Defense Advanced Research Projects Agency (Contract no. 140D6319C00236)
- European Commission (DIAMONDS (Horizon 2020; grant 848196) and PERFORM (Horizon 2020 grant 668303))
- National Institute for Health and Care Research (see below)
- Wellcome 4i NIHR Imperial BRC PhD Fellowship, grant RDA02 NIHR Imperial Biomedical Research Centre NIHR Imperial Clinical Research Facility Kwok Foundation
This publication has 72 references indexed in Scilit:
- Influenza and the risk of active tuberculosis occurrence among individuals with latent tuberculosis infection: A national cohort study in South Korea (2015–2020)Journal of Microbiology, Immunology and Infection, 2024
- Blood transcriptional correlates of BCG-induced protection against tuberculosis in rhesus macaquesCell Reports Medicine, 2023
- Cytomegalovirus acquisition in infancy and the risk of tuberculosis disease in childhood: a longitudinal birth cohort study in Cape Town, South AfricaThe Lancet Global Health, 2021
- Host transcriptional response to TB preventive therapy differentiates two sub-groups of IGRA-positive individualsTuberculosis, 2021
- Concise whole blood transcriptional signatures for incipient tuberculosis: a systematic review and patient-level pooled meta-analysisThe Lancet Respiratory Medicine, 2020
- In vitro mycobacterial growth inhibition assays: A tool for the assessment of protective immunity and evaluation of tuberculosis vaccine efficacyVaccine, 2016
- The influence of influenza virus infections on the development of tuberculosisTuberculosis, 2013
- The 1918 influenza pandemic hastened the decline of tuberculosis in the United States: An age, period, cohort analysisVaccine, 2011
- An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosisNature, 2010
- Mapping identifiers for the integration of genomic datasets with the R/Bioconductor package biomaRtNature Protocols, 2009